Has Sanjay Shah, MD received payments from drug or device companies?

Yes. Drug and device makers reported $64,702 in general payments to Sanjay Shah, MD across 1,285 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sanjay Shah, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sanjay Shah, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sanjay Shah, MD

Pain Medicine · Spring House, PANPI 1770558413

Payments from drug & device makers

$64,702in general payments, 2019–2025

Across 1,285 payments — averaging $50.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Surgentec$28K
Abbott$12K
Vertos Medical, Inc.$5K
Collegium Pharmaceutical, Inc.$3K
Boston Scientific$3K
MML US, Inc.$2K
plus $13K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Surgentec	10	$28,063
Abbott	392	$11,630
Vertos Medical, Inc.	80	$4,980
Collegium Pharmaceutical, Inc.	159	$2,672
Boston Scientific	161	$2,562
MML US, Inc.	28	$1,912
Spinal Simplicity, LLC	16	$1,500
Nalu Medical, Inc.	7	$1,189
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	82	$1,138
Vertiflex, Inc.	10	$1,010
Scilex Pharmaceuticals Inc.	40	$885
AbbVie(2 entities)	44	$863
Relievant Medsystems, Inc.	9	$852
Nevro Corp.	15	$553
Medtronic(2 entities)	19	$478
Valinor Pharma, LLC	19	$320
Stryker	5	$265
Averitas Pharma Inc.	14	$258
Si-bone, Inc.	4	$220
IBSA Pharma Inc.	9	$212
MDD US Operations, LLC	8	$197
Forte Bio-pharma LLC	4	$187
Foundation Fusion Solutions, LLC	16	$163
Pfizer	8	$158
Vertex	6	$153
Kowa Pharmaceuticals America, Inc.	14	$147
Lilly USA, LLC	9	$146
Saluda Medical Americas, Inc.	4	$125
Amarin Pharma, Inc.	1	$125
Redhill Biopharma Inc.	7	$120
Fidia Pharma USA Inc.	6	$118
Radius Health, Inc.	7	$118
Teva Pharmaceuticals USA, Inc.	6	$105
GRT US Holding, Inc.	6	$104
E.r. Squibb & Sons, L.L.C.	1	$99
Pacira Therapeutics, Inc.	4	$92
Lundbeck LLC	4	$89
Biodelivery Sciences International, Inc.	5	$89
Biotronik NRO, Inc.	4	$82
Almatica Pharma LLC	4	$78
Currax Pharmaceuticals LLC	5	$74
Painteq LLC	2	$54
Arbor Pharmaceuticals, Inc.	3	$45
Biohaven Pharmaceutical Holding Company Ltd.	2	$45
Appliedvr Inc	2	$40
Curonix LLC	1	$40
Protega Pharmaceutials Inc	2	$36
Electronic Waveform Lab, Inc.	4	$34
Bioventus LLC	1	$34
Azurity Pharmaceuticals, Inc.	2	$33
Amgen(2 entities)	2	$29
Stimwave Technologies Incorporated	2	$27
Tersera Therapeutics LLC	2	$23
Novartis	1	$22
Amneal Pharmaceuticals LLC	1	$21
Virtus Pharmaceuticals LLC	1	$17
Kaleo, Inc.	1	$15
Siemens Medical Solutions USA, Inc.	1	$15
Pacira Pharmaceuticals Incorporated	1	$14
Daiichi Sankyo Inc.	1	$14

How this compares

$64,702 in reported general payments places this provider in the 95th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$1,278,035

Medicare patients

1,139

Services billed

31,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Spring House

Daniel GruenerPhiladelphia$2.9M
Peter PryzbylkowskiPhiladelphia$508K
Yeshvant NavalgundGreensburg$388K
Jack SmithWilliamsport$324K
Sanjay GuptaBala Cynwyd$241K
Vwaire OrhurhuWilliamsport$191K
Philip KimBryn Mawr$178K
Farooq QureshiQuakertown$130K
Matthew DrakeleyCoraopolis$99K
Bruce NicholsonAllentown$85K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →